| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $28.9B | $20.8B | $4.3B | $3.0B | $2.1B | $1.3B | $0.7B | $0.4B |
| Cost of Revenue | $16.0B | $11.2B | $7.3B | $5.4B | $4.1B | $2.3B | $1.2B | $0.7B |
| Gross Profit | $12.9B | $9.6B | $2.0B | $1.5B | $0.9B | $0.5B | $0.3B | $0.2B |
| R&D Expense | $2.3B | $1.9B | $1.8B | $1.1B | $0.6B | $0.4B | $0.2B | $0.1B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $3.2B | $2.6B | $1.8B | $1.0B | $0.4B | $0.1B | $-0.2B | $-0.1B |
| Net Income | $2.0B | $1.9B | $0.2B | $0.2B | $-0.0B | $-0.1B | $-0.1B | $-0.0B |
| EPS (Basic) | $39.40 | $37.69 | $3.26 | $3.28 | $-0.92 | $-1.02 | $-1.11 | $-0.05 |
| EPS (Diluted) | $39.40 | $37.69 | $3.25 | $3.25 | $-0.92 | $-1.02 | $-1.11 | $-0.05 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $42.7B | $25.2B | $17.6B | $13.7B | $10.1B | $6.5B | $4.8B | $2.2B |
| Current Assets | $33.6B | $20.1B | $14.3B | $11.0B | $8.2B | $5.3B | $3.8B | $1.5B |
| Cash & Equivalents | $3.7B | $2.6B | $2.6B | $1.9B | $2.6B | $1.9B | $1.4B | $0.4B |
| Total Liabilities | $35.9B | $20.8B | $14.6B | $11.9B | $8.6B | $4.9B | $2.7B | $1.9B |
| Current Liabilities | $28.6B | $16.6B | $11.3B | $8.6B | $5.8B | $3.6B | $1.8B | $1.2B |
| Stockholders' Equity | $6.7B | $4.4B | $3.1B | $1.8B | $1.5B | $1.7B | $2.0B | $0.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $12.1B | $7.9B | $5.1B | $2.9B | $1.0B | $1.2B | $0.5B | $0.2B |
| Investing Cash Flow | $-6.2B | $-8.3B | $-3.5B | $-3.9B | $-1.6B | $-0.3B | $-1.4B | $-0.7B |
| Capital Expenditures | — | — | $0.5B | $0.5B | $0.6B | $0.2B | $0.1B | $0.1B |
| Financing Cash Flow | $2.9B | $2.0B | $-0.3B | $0.9B | $1.9B | $0.2B | $2.0B | $0.6B |